Enoximone sulfoxide enantiomers and their use in the treatment of PDE-III mediated diseases

摘要

The present invention provides the (S)-(-) enoximone sulfoxide enantiomer, as well as pharmaceutical formulations of the purified (S)-(-) sulfoxide enantiomer. Also provided are methods of treating diseases in which inhibition of PDE-III may be beneficial.